There has been significant evolution in the European regulatory landscape over the past 10–15 years, particularly with respect to requirements for clinical evaluation.
This white paper will focus on the purpose of the clinical evaluation, some of the embedded requirements that may not be immediately obvious to all manufacturers, and in particular the importance of clinical evaluation planning and scope.
